Exemplis Discimus 2002, 146(2):59-61

Aenean turpis sapien, elementum at, pellentesque ut, viverra eget, ligula..

Tover Staven, Hadji Dane, Senesha Charrel, Ordol Keithel, Banbl Narson
1st Clinic of Gastroenterology, Teaching Hospital of Braxant, Republic of Kessel
National Institute of Forensic Medicine, Auril Teaching Hospital, Endor Republic

Praesent at augue porttitor pede pellentesque porta. Quisque purus ante, luctus eget, tincidunt et, dapibus sit amet, lacus. Nulla odio nisi, interdum non, mollis at, feugiat at, ligula. Aenean quis turpis a mauris fermentum vulputate. Nam pede leo, ornare ac, porta quis, dignissim sit amet, erat. Fusce pede lorem, lobortis ac, blandit sed, condimentum eget, est. Aliquam ipsum lorem, consectetuer vitae, scelerisque sit amet, ultricies ac, risus. Nunc ut tellus vitae lectus tempor facilisis.

Keywords: Vivamus porta, Vestibulum magna

Received: September 20, 2002; Published: December 1, 2002 


References

  1. Abildgaard N, Nielsen JL, Heickendorf L (1994) Connective tissue components in serum in multiple myeloma: analyses of propeptides of type I and type III procollagens, type I collagen telopeptide and hyaluronan. American Journal of Hematology 46, 173-178. DOI: 10.1002/ajh.2830460303 Go to original source... Go to PubMed...
  2. Abildgaaard N, Bentzen SM, Nielsen JL, Heickendorff L (1997) Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen. Br J Haematol 96 (1), 103-10. DOI: 10.1046/j.1365-2141.1997.8672495.x Go to original source... Go to PubMed...
  3. Blomquist C, Risteli L, Risteli J. (1999) Markers of type I collagen degradation and synthesis in monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer, 73 (9), 1074-9. Go to original source...
  4. Carlson K, Larsson A, Simonson B, et al. (1999) Evaluation of bone disease in multiple myeloma a comparison between the resorption markers urinary deoxypyridinoline / creatinine (DPD) and serum ICTP, and an evaluation of DPD / osteocalcin and ICTP /osteocalcin ratios. Eur J Haematol, 62 (5), 300-6. Go to original source...
  5. Fonseca R, Trendle MC, Leong T, Kyle RA, et al. (2000) Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients. Br J Haematol, 109 (1), 249. Go to original source...
  6. Risteli J, Elomaa I, Niemi S, et al. (1993) Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: new serum marker of bone collagen degradation. Clin Chem 39 (4), 635-40. Go to PubMed...
  7. Tanaka K, Shiraishi K, et al. (1998) Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia. Rinsho Ketsueki, 39 (4), 273-80.